Article
The clinical significance of the expression of PROM1/CD133, NOTCH2 and CDK4 in triple-negative breast cancer
2023-12-11
Abstract excerpt
<h4>Purpose: </h4> The aim of this study is to investigate the expression of cyclin kinase 4 (CDK4), PROM1/CD133 (CSC marker), and NOTCH2 proteins in triple negative breast cancer (TNBC), and to determine their correlation with clinicopathological parameters and survival prognosis. Additionally, we aim to explore the prognostic value of co-expression in TNBC. <h4>Method: </h4> In this study, we utilized the GEPIA...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 19600110-ba45-5a49-aa18-b2ebef7b1c12
- DOI
- 10.21203/rs.3.rs-3715135/v1
